162 related articles for article (PubMed ID: 18705322)
1. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?
Sikorska K; Stalke P; Jaskiewicz K; Romanowski T; Bielawski KP
Hepatogastroenterology; 2008; 55(84):1024-8. PubMed ID: 18705322
[TBL] [Abstract][Full Text] [Related]
2. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.
Cukjati M; Vaupotic T; Rupreht R; Curin-Serbec V
BMC Med Genet; 2007 Nov; 8():69. PubMed ID: 18036208
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
5. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
[TBL] [Abstract][Full Text] [Related]
6. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
[TBL] [Abstract][Full Text] [Related]
7. HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment.
Sikorska K; Bielawski KP; Stalke P; Lakomy EA; Michalska Z; Witczak-Malinowska K; Romanowski T
Int J Mol Med; 2005 Dec; 16(6):1151-6. PubMed ID: 16273299
[TBL] [Abstract][Full Text] [Related]
8. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in a Venezuelan sample.
Vizzi E; Loureiro CL; Gerder M; de las Nieves Garcia-Casal M; Rodríguez-Larralde A; Gerace L; Ludert JE; Liprandi F; Pujol FH
Ann Hematol; 2005 Nov; 84(12):802-6. PubMed ID: 15995871
[TBL] [Abstract][Full Text] [Related]
10. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
11. [The importance of DNA analysis of C282Y, H63D and S65C mutations in the HFE gene].
Drastíková M; Beránek M; Hegerová J; Putzová D
Cas Lek Cesk; 2012; 151(9):428-31. PubMed ID: 23102134
[TBL] [Abstract][Full Text] [Related]
12. The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.
Sikorska K; Stalke P; Izycka-Swieszewska E; Romanowski T; Bielawski KP
Med Sci Monit; 2010 Mar; 16(3):CR137-143. PubMed ID: 20190684
[TBL] [Abstract][Full Text] [Related]
13. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.
Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS
Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041
[TBL] [Abstract][Full Text] [Related]
15. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
[TBL] [Abstract][Full Text] [Related]
16. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
[TBL] [Abstract][Full Text] [Related]
17. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
[TBL] [Abstract][Full Text] [Related]
18. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
[TBL] [Abstract][Full Text] [Related]
19. Frequency of HFE H63D, S65C, and C282Y mutations in patients with iron overload and controls from Toledo, Spain.
de Diego C; Murga MJ; Martínez-Castro P
Genet Test; 2004; 8(3):263-7. PubMed ID: 15727249
[TBL] [Abstract][Full Text] [Related]
20. Analysis of HFE gene mutations (C282Y, H63D, and S65C) in the Ecuadorian population.
Leone PE; Giménez P; Collantes JC; Paz-y-Miño C
Ann Hematol; 2005 Feb; 84(2):103-5. PubMed ID: 15517265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
